Holdings

Symbol Grade Price % Change Allocation
ABBV D -0.56 0.24
BAC B -0.19 0.23

Recent News for iShares Intermediate-Term Corporate Bond ETF & its Holdings

Date Stock Title
May 2 BAC Bank of America closes 7th straight session of loss
May 2 ABBV Top 25 Stocks in the S&P 500 by Index Weight Right Now
May 2 BAC Whether Wall Street garden leaves survive noncompete ban is an 'open question'
May 2 ABBV The top pharmaceutical companies by R&D expenditure
May 2 BAC Without transparency, banks will continue to find themselves as political prey
May 1 ABBV BeiGene, AbbVie patent spat to get trial from USPTO appeals board
May 1 BAC Bank Of America, Fifth Third Bancorp To Gain From 'Higher For Longer' Interest Rates: JPMorgan's Top Picks
May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
May 1 BAC U.S. banking regulators push to rework Basel III endgame rule - report
May 1 BAC BofA Survey: Majority of Small and Mid-Sized Business Owners Anticipate Revenue Growth This Year
May 1 BAC More Than 10% of Warren Buffett-Led Berkshire Hathaway's $374 Billion Portfolio Is Invested in This Stock. Should You Buy It?
May 1 BAC Whether Wall Street garden leaves survive non-compete ban is an 'open question'
Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
Apr 30 ABBV AbbVie (ABBV) Could Be a Great Choice
Apr 30 ABBV AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Apr 30 BAC How To Earn $500 A Month From Bank of America Stock Following Upbeat Q1 Earnings
Apr 30 ABBV Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 29 ABBV AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Apr 29 ABBV AbbVie: The Inevitable Is Happening
Apr 29 ABBV Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)
The investment seeks to track the investment results of the ICE BofAML 5-10 Year US Corporate Index. The fund generally invests at least 90% of its assets in securities of the underlying index. The index measures the performance of investment-grade corporate bonds that are U.S. dollar-denominated and have a remaining maturity of greater than or equal to five years and less than ten years. The fund may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents.
Exchange Traded Fund ETF Bond Bond Market Corporate Bond Swaps Equity Derivative
Back to the Main IGIB Page...